EGElisabetta Gargioni

Elisabetta Gargioni

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Elisabetta Gargioni has a total of 262 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Multicenter evaluation of total body irradiation planning strategies: A DGMP working group study on large-field irradiation techniques

    by Maya Shariff, Heiko Karle, Oliver Schramm, Johann Brand, Andre Karius, Sven Knobe, Hendrik Auerbach, Jerome Krayenbuehl, Sebastian Neppl, Julia Kirschke, et al.

  • Open Access

    PEERing into the Future: Benchmarking the ANSTO Australian Synchrotron’s Very-High-Energy Electron Linac for Ultra-High Dose-Rate, In Vivo FLASH Radiotherapy Research

    by James Cayley, Elette Engels, Tessa Charles, Kiarn Roughley, Marie Wegner, Sarah Koschny, Kirsty Brunt, Matthew Cameron, Daniel Hausermann, Paul Bennetto, et al.

    Background/Objectives: The PEER beamline at the ANSTO Australian Synchrotron has been developed to enable VHEE FLASH radiotherapy studies, both dosimetric and biological. Featuring a 100 MeV electron linac, it delivers single or multi-pulse irradiations consisting of 100 ps bunches with a 2 ns spacing, resulting in average dose-rates and instantaneous dose-rates as high as 108 Gy/s and 109 Gy/s, respectively. Much work has been conducted to realise a stable accelerator facility, complete with the tooling and diagnostics required to undertake such studies. However, to truly confirm its suitability required a successful biological benchmarking. Methods: Three cell lines were irradiated utilising real-time dosimetry to compare linear quadratic cell survival curves with other facilities. Also, mouse cadavers were transported and irradiated, mimicking live animals, to assess the feasibility and logistics of small animal experiments. Results: By comparing the trends of the linear quadratic model, evident in the α and β parameters, the PEER cell survival results were shown to be in agreement with VHEE results from the ARES beamline at DESY, Hamburg, Germany. Evident in the survival trends, VHEE produced more cell sparing in all cell lines compared to 2 Gy/s X-rays delivered on the IMBL, another beamline at the Australian Synchrotron. The results of the mouse cadaver irradiations showed that PEER can safely and efficiently irradiate small animals. Conclusions: The PEER beamline is shown to possess suitable capabilities, including real-time dosimetry, repeatable alignment, and linac diagnostics, rendering it suitable for future in vivo VHEE UHDR FLASH radiotherapy investigations.


  • Open Access

    A procedure for accurate dose measurement in radiotherapy research at millimetre-sized synchrotron beams

    by Catharina Mewes, Michael Lerch, Marco Petasecca, Johannes Klingenberg, Guilherme Abreu Faria, Ulrich Lienert, Elisabeth Schültke, Jason Paino, James Cayley, Marie Wegner, et al.

    Objective. Synchrotron-based spatially fractionated radiotherapy and ultra-high dose rate (UHDR) radiotherapy have been shown to better spare healthy tissue function in comparison to conventional radiotherapy, while controlling the tumour with the same efficacy. In recent years, an increasing amount of research has been carried out in these fields with promising results. However, further experiments remain essential, since the underlying mechanisms of healthy tissue preservation are not yet fully understood. The characterisation of synchrotron beamlines at the Deutsches Elektronen-Synchrotron in Hamburg represents an opportunity to increase the number of sites where pre-clinical studies could be conducted in the future. However, the beams available at this synchrotron are only a few millimetres in size and measuring absorbed dose with established detectors and dosimetry protocols represents a challenge. Approach. We show a procedure to accurately determine the beam dose rate under such conditions by first characterising a monochromatic beamline. After validation, and with the support of Monte Carlo simulations, the procedure is adapted to investigate a white-beam beamline, at which photon flux and mean energy can be varied with Cu absorbers. Main results. With the developed procedure, it is possible to measure absorbed dose at these beamlines with relative uncertainties below 10%. In particular, at the white-beam beamline, the dose rate varies between about 20 Gy s −1 and about 1800 Gy s −1 , thus offering the opportunity to carry out much-needed systematic studies. Moreover, pilot experiments with a mouse phantom demonstrate that it is possible to treat small animals with such small-sized beams by using dose-painting techniques, with an agreement between prescribed and delivered dose within ±15%. Significance . This work represents a first step towards the implementation of reproducible pre-clinical studies at the PETRA III synchrotron, further contributing to a transition of spatially-fractionated and UHDR radiotherapy techniques into clinical practice.

  • Open Access

    Spatial Proteomics Reveals Distinct Protein Patterns in Cortical Migration Disorders Caused by LIN28A Overexpression and WNT Activation

    by Jelena Navolić, Sara Hawass, Manuela Moritz, Jan Hahn, Maximilian Middelkamp, Antonia Gocke, Matthias Dottermusch, Yannis Schumann, Lisa Ruck, Christoph Krisp, et al.


  • Open Access

    Development and characterization of modular mouse phantoms for end-to-end testing and training in radiobiology experiments

    by Marie Wegner, Thorsten Frenzel, Dieter Krause, Elisabetta Gargioni

    Objective . In radiation oncology, experiments are often carried out using mice as a model for in vivo research studies. Due to recent technological advances in the development of high-precision small-animal irradiation facilities, the importance of quality assurance for both dosimetry and imaging is increasing. Additive manufacturing (AM) offers the possibility to produce complex models from a three-dimensional data set and to build cost-effective phantoms that can easily be adapted to different purposes. The aim of this work was therefore to develop detailed anatomical mouse models for quality assurance and end-to-end testing of small-animal irradiation and imaging by means of AM. Approach . Two mouse phantom concepts were designed, constructed, and examined for this purpose. The first model includes cavities corresponding to the most important organs. The final solid model was constructed using AM in two separate parts that can be attached with a plug connection after filling these cavities with tissue-equivalent mixtures. Moreover, different radiation dosimeters can be placed in the lower part of the model. For the second concept, AM was used for building modules like the phantom outer shell and bones, so that different mixtures can be used as a filling, without modifying the phantom structure. Main results. CT as well as Micro-CT scans of both concepts showed an excellent quality and adequate image contrast, with material attenuation properties close to those of mouse tissues, apart from the current bone surrogates. Radiation dose measurements with radiochromic films were, with some exceptions in areas with larges bone volumes, in agreement with calculations within less than ±4%. Significance . AM shows great potential for the development of mouse models that are inexpensive, easy to adapt, and accurate, thus enabling their use for quality assurance in small-animal radiotherapy and imaging. The introduction of such 3D-printable mouse phantoms in the workflow could also significantly reduce the use of living animals for optimization and testing of new imaging and irradiation protocols.


  • Open Access

    The Microbeam Insert at the White Beam Beamline P61A at the Synchrotron PETRA III/DESY: A New Tool for High Dose Rate Irradiation Research

    by Elisabeth Schültke, Stefan Fiedler, Catharina Mewes, Elisabetta Gargioni, Johannes Klingenberg, Guilherme Abreu Faria, Michael Lerch, Marco Petasecca, Franziska Prehn, Marie Wegner, et al.

    High dose rate radiotherapies such as FLASH and microbeam radiotherapy (MRT) both have developed to the stage of first veterinary studies within the last decade. With the development of a new research tool for high dose rate radiotherapy at the end station P61A of the synchrotron beamline P61 on the DESY campus in Hamburg, we increased the research capacity in this field to speed up the translation of the radiotherapy techniques which are still experimental, from bench to bedside. At P61, dose rates of several hundred Gy/s can be delivered. Compared to dedicated biomedical beamlines, the beam width available for MRT experiments is a very restrictive factor. We developed two model systems specifically to suit these specific technical parameters and tested them in a first set of experiments.


  • Open Access

    In-situ x-ray fluorescence imaging of the endogenous iodine distribution in murine thyroids

    by Christian Körnig, Theresa Staufer, Oliver Schmutzler, Tanja Bedke, Andres Machicote, Beibei Liu, Yang Liu, Elisabetta Gargioni, Neus Feliu, Wolfgang J. Parak, et al.

    X-ray fluorescence imaging (XFI) is a non-invasive detection method of small quantities of elements, which can be excited to emit fluorescence x-ray photons upon irradiation with an incident x-ray beam. In particular, it can be used to measure nanoparticle uptake in cells and tissue, thus making it a versatile medical imaging modality. However, due to substantially increased multiple Compton scattering background in the measured x-ray spectra, its sensitivity severely decreases for thicker objects, so far limiting its applicability for tracking very small quantities under in-vivo conditions. Reducing the detection limit would enable the ability to track labeled cells, promising new insights into immune response and pharmacokinetics. We present a synchrotron-based approach for reducing the minimal detectable marker concentration by demonstrating the feasibility of XFI for measuring the yet inaccessible distribution of the endogenous iodine in murine thyroids under in-vivo conform conditions. This result can be used as a reference case for the design of future preclinical XFI applications as mentioned above.


  • Open Access

    X-ray Fluorescence Uptake Measurement of Functionalized Gold Nanoparticles in Tumor Cell Microsamples

    by Oliver Schmutzler, Sebastian Graf, Nils Behm, Wael Y. Mansour, Florian Blumendorf, Theresa Staufer, Christian Körnig, Dina Salah, Yanan Kang, Jan N. Peters, et al.

    Quantitative cellular in vitro nanoparticle uptake measurements are possible with a large number of different techniques, however, all have their respective restrictions. Here, we demonstrate the application of synchrotron-based X-ray fluorescence imaging (XFI) on prostate tumor cells, which have internalized differently functionalized gold nanoparticles. Total nanoparticle uptake on the order of a few hundred picograms could be conveniently observed with microsamples consisting of only a few hundreds of cells. A comparison with mass spectroscopy quantification is provided, experimental results are both supported and sensitivity limits of this XFI approach extrapolated by Monte-Carlo simulations, yielding a minimum detectable nanoparticle mass of just 5 pg. This study demonstrates the high sensitivity level of XFI, allowing non-destructive uptake measurements with very small microsamples within just seconds of irradiation time.